Share on LinkedInShare on LinkedIn

ARTICLE · 14 JULY 2020

Bipartisan Bill Proposes To Leverage CFIUS In Assessing Pharmaceutical Supply Chain

On June 30, 2020, United States Senators Elizabeth Warren (D-Mass.) and Marco Rubio (R-Fla.) introduced legislation proposing the Committee on Foreign Investment in the United States.

United StatesGovernment, Public Sector

On June 30, 2020, United States Senators Elizabeth Warren (D-Mass.) and Marco Rubio (R-Fla.) introduced legislation proposing the Committee on Foreign Investment in the United States (CFIUS), an interagency committee authorized to review certain transactions involving foreign investment in the United States for national security concerns, and assist the Federal Trade Commission (FTC) in "conduct[ing] a study on the United States' overreliance on foreign countries and the impact of foreign direct investment in the U.S. pharmaceutical industry." In the last decade, CFIUS reviewed a number of mergers and acquisitions in the healthcare industry that resulted in a foreign person obtaining control of a U.S. pharmaceutical supplier, among other pharma entities. More recently, CFIUS jurisdiction was expanded to include not only the review of transactions that result in foreign control of a U.S. business, but also certain non-controlling foreign investments as well, including

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

This article is presented for informational purposes only and is not intended to constitute legal advice.

See more popular content from